Optimal Regimens for the Mobilization and Collection of Peripheral Blood Progenitor Cells from Normal Donors

References

• Sheridan W. P., Begley C. G., Juttner C. A., Szer J., To L. B., Maher D., McGrath K. M., Morstyn G., Fox R. M. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640
   PubMed Web of Science ®Google Scholar
• Chao N. J., Schriber J. R., Grimes K., Long G. D., Negrin R. S., Raimondi C. M., Homing S. J., Brown S. L., Miller L., Blume K. G. Granulocyte colony-stimulating factor “mobilized” peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031
   PubMed Web of Science ®Google Scholar
• Bensinger W., Singer J., Appelbaum F., Lilleby K., Longin K., Rowley S., Clarke E., Clift R., Hansen J., Shields T., Storb R., Weaver C., Weiden P., Buckner C. D. Autologous transplantation with peripheral blood mononu-clear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Begley C. G., To L. B., Grigg A., Szer J., Maher M. D., Rowlings P. A., McGrath K. M., Cebon J., Dyson P., Watson D., Bayly J., de Luca E., Tomita D., Hoffman E., Morstyn G., Juttner C. A., Fox R. M. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemo-poiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994; 14: 105
   PubMed Web of Science ®Google Scholar
• Rosenthal M. A., Grigg A. P., Sheridan W. P. High dose busulphan/cyclophosphamide for autologous bone marrow transplantation is associated with minimal non-hemopoietic toxicity. Leuk. Lymphoma 1994; 14: 279–283
   PubMed Web of Science ®Google Scholar
• Schmitz N., Linch D. C., Dreger P., Goldstone A. H., Boogaerts M. A., Ferrant A., Demuynck H. M. S., Link H., Zander A., Barge A., Borkett K. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353–357
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Clift R. A., Anasetti C., Appelbaum F. A., Demirer T., Rowley S., Sandmaier B. M., Torok-Storb B., Storb R., Buckner D. Transplantation of allo-geneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 1996; 14: 90–105
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Oku N., Ashihara E., et al. Collection of peripheral blood stem cells mobilised by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant 1992; 10: 341–346
   PubMed Web of Science ®Google Scholar
• Lickliter J., Begley C. G., Boyd A., Grigg A. P. Combined chemotherapy and granulocyte colony-stimulating factor mobilise large numbers of peripheral blood progenitor cells in pretreated patients. Leuk. Lymphoma 1994; 15: 91–97
   PubMed Web of Science ®Google Scholar
• Grigg A. P., Roberts A. W., Raunow H., Houghton S., Layton J. E., Boyd A. W., McGrath K. M., Maher D. Optimising dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437
   PubMed Web of Science ®Google Scholar
• Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Eng. J. Med. 1992; 32: 27–35
   Google Scholar
• Tanaka J., Imamura M., Zhu X., Kobayashi S., Imai K., Hashino S., Sakurada K. Potential benefit of recombinant human granulocyte colony-stimulating factor-mobilised peripheral blood stem cells for allogeneic transplantation. Blood 1994; 8: 3595
   Google Scholar
• Surue T., Kawano Y., Takaue Y., et al. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by human granulocyte colony-stimulating factor. Exp. Hematol. 1994; 22: 888–892
   PubMed Web of Science ®Google Scholar
• Schmitz N., Dreger P., Suttorp M., Rohwedder E. B., Haferlach T., Löffler H., Hunter A., Russell N. H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666
   PubMed Web of Science ®Google Scholar
• Dreger P., Haferlach T., Eckstein V., Jacobs S., Suttorp M., Loftler H., Müller-Ruchholtz W., Schmitz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br. J. Hematol. 1994; 87: 609
   PubMed Web of Science ®Google Scholar
• Lane T. A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L. W. M. M., Hardwick A., Moubayed M., Oldham F., Corringham R. E. T., Ho A. D. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275
   PubMed Web of Science ®Google Scholar
• Körbling M., Przepiorka D., Huh Y. O., Engel H., van Besien K., Giralt S., Anderson B., Kleine H. D., Seong D., Deisseroth A. B., Andreeff M., Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Weaver C. H., Appelbaum F. R., Rowley S., Demirer T., Sanders J., Storb R., Buckner C. D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655
   PubMed Web of Science ®Google Scholar
• Roberts A. W., DeLuca E., Begley C. G., Basser R., Grigg A. P., Metcalf D. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 1995; 13: 512–516
   PubMed Web of Science ®Google Scholar
• Weaver C. H., Hazelton B., Palmer P. A., Li W., Birch R., Alberico T., West W. H., Schwartzberg L. S. A randomized dose finding study of filgrastim for mobilization of peripheral blood progenitor cells (PBPCs). Proc. ASC 1996; 990a
   Google Scholar
• Sato N., Sawada K., Takahashi T. A., Mogi Y., Asano S., Koike T., Sekiguchi S. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp. Hematol. 1994; 22: 973–978
   PubMed Web of Science ®Google Scholar
• Champlin R., Andrellini P., Przepiorka D., Seong D., Korbling M. Allogeneic transplantation of peripheral blood progenitor cells. Second International Symposium Cytokines in Bone Marrow Transplantation. March, 21–231996, 93
   Google Scholar
• Anderlini P., Lauppe J., Huh Y. O., Przepiorka D., Seong D., Champlin R., Korbling M. The apheresis yield of CD34+ progenitor cells from normal donors is dependent on the duration of filgrastim mobiliration. Blood 1995; 86(Suppl 1)406a
   Google Scholar
• Socinski M. A., Cannistra S. A., Elias A., Antman K. H., Schnipper L., Griffin J. D. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194
   PubMed Web of Science ®Google Scholar
• Winter J. N., Lazarus H. M., Rademaker A., Villa M., Mangan C., Tallman M., Jahnke L., Gordon L., Newman S., Byrd K., Cooper B. W., Horvath N., Crum E., Stadtmauer E. A., Conklin E., Bauman A., Martin J., Goolsby C., Gerson S. L., Bender J., O'Gorman M. Phase VII study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells. J. Clim Oncol. 1996; 14: 277–286
   PubMed Web of Science ®Google Scholar
• Basser R., Begley C. G., Mansfield R., To B., Juttner C., Maher D., Fox R. J., Cebon J., Grigg A., Clark K., Marty J., Menchaca D., Thompson B., Russell I., Collins J., Green M. Mobilization of PBPC by priming with stem cell factor (SCF) before filgrastim compared to concurrent administration. Blood 1995; 86(Suppl 1)687a
   Google Scholar
• Laterveer L., Lindley I. J. D., Hamilton M. S., Willemze R., Fibbe W. E. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995; 85: 2269–2275
   PubMed Web of Science ®Google Scholar
• Lord B. I., Woolford L. B., Wood L. M., Czaplewski L. G., McCourt M., Hunter M. G., Edwards R. M. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-l alpha. Blood 1995; 85: 3412–3415
   PubMed Web of Science ®Google Scholar
• Basser R., To L. B., Begley C. G., Juttner C. A., Maher D. W., Szer J., Cebon J., Collins J. P., Russell I., Olver I., Gill P. G., Fox R. M., Sheridan W. P., Green M. D. Adjuvant treatment of high risk breast cancer using multi-cycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clin. Cancer Res.
   Google Scholar
• Haylock D. N., To L. B., Dowse T. L., Juttner C. A., Simmons P. J. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405
   PubMed Web of Science ®Google Scholar
• Brugger W., Heimfeld S., Berenson R. J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Eng. J. Med. 1995; 33: 283
   Web of Science ®Google Scholar
• Dunbar C. E., Cottler-Fox M., O'Shaughnessy J. A., Doren S., Carter C., Berenson R., Brown S., Moen R. C., Greenblatt J., Stewart F. M., Leitman S. F., Wilson W. H., Cowan K., Young N. S., Nienhuis A. W. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048–3057
   PubMed Web of Science ®Google Scholar
• Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., Iacucci R., Zei T., Martelli M. P., Gambelunghe C., et al. Successful eiigraftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in leukemia patients by addition of recombinant granulocyte colony-stimulating factor-mobilired peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948–3955
   PubMed Web of Science ®Google Scholar